Literature DB >> 1346411

Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children.

R Goldsmith1, P O Yarbough, G R Reyes, K E Fry, K A Gabor, M Kamel, S Zakaria, S Amer, Y Gaffar.   

Abstract

Hepatitis E virus (HEV) is thought to be a cause of enterically transmitted non-A, non-B (ET-NANB) hepatitis. Waterborne epidemics have been recorded in many developing countries, mainly affecting young-to-middle-aged adults; sporadic infection and overt illness in children are rare. However, a convenient and sensitive diagnostic test for HEV infection is not yet available. We now report the use of a solid-phase enzyme-linked immunoassay (ELISA) that detects IgM and IgG antibody to HEV. In a prospective study of endemic acute hepatitis during 1986 in rural Benha, Egypt, 15 (42%) of 36 children with NANB hepatitis (from whom convalescent-phase sera were available every 3 months to 9 or 12 months) were positive for anti-HEV-IgG by ELISA. Of 20 sera from healthy Benha children (controls), 5 (25%) were also positive for anti-HEV-IgG. When evaluated for anti-HEV-IgM, 6 of the 15 IgG-positive children, but none of the controls, were IgM positive and were thus regarded as having confirmed acute HEV infections. These 6 cases together with 2 presumptive cases (IgM negative, IgG seroconversion from positive to negative) presented sporadically over 9 months. This ELISA is a convenient method for the diagnosis of HEV infection; we have shown that the disease is present in Egypt, that it can occur endemically as sporadic cases, and that children do have overt infection.

Entities:  

Keywords:  Africa; Age Factors; Antibodies--analysis; Arab Countries; Biology; Child; Demographic Factors; Developing Countries; Diseases; Egypt; Examinations And Diagnoses; Hematologic Tests; Hepatitis; Immunity; Immunologic Factors; Laboratory Examinations And Diagnoses; Laboratory Procedures; Mediterranean Countries; Northern Africa; Physiology; Population; Population Characteristics; Prospective Studies; Research Methodology; Studies; Viral Diseases; Youth

Mesh:

Substances:

Year:  1992        PMID: 1346411     DOI: 10.1016/0140-6736(92)91647-q

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  36 in total

1.  Approaches of the diagnosis of hepatitis viruses.

Authors:  G J Kotwal
Journal:  Mol Biotechnol       Date:  2000-11       Impact factor: 2.695

2.  Seroepidemiological study of hepatitis E virus in different population groups.

Authors:  M C Bernal; A Leyva; F Garcia; I Galan; G Piedrola; H Heyermann; M C Maroto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

3.  Viral superinfection in previously unrecognized chronic carriers of hepatitis B virus with superimposed acute fulminant versus nonfulminant hepatitis.

Authors:  C M Chu; C T Yeh; Y F Liaw
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

4.  Outbreak of Viral Hepatitis E in a Regimental Training Centre.

Authors:  A Banerjee; A K Sahni; A Nagendra; G S Saiprasad
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  HAV and HEV infection in hospitalised hepatitis patients in Alexandria, Egypt.

Authors:  M Divizia; R Gabrieli; M L Stefanoni; E Renganathan; E El Ghazzawi; O A Kader; F Gamil; G El Sawaf; E El Sherbini; E Saleh; A M Degener; A Noce; L Zaratti; A Modesti; A Panà
Journal:  Eur J Epidemiol       Date:  1999-08       Impact factor: 8.082

6.  Identification of novel human hepatitis E virus (HEV) isolates and determination of the seroprevalence of HEV in Korea.

Authors:  Jeong-Min Ahn; Sang-Gyun Kang; Deog-Yong Lee; Sung Jae Shin; Han Sang Yoo
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

7.  Age-specific seroepidemiology of hepatitis A, B, and E infections among children in Istanbul, Turkey.

Authors:  M Sidal; E Unüvar; F Oğuz; C Cihan; D Onel; S Badur
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 8.  Liver disease.

Authors:  S D Ryder; R Williams
Journal:  Postgrad Med J       Date:  1994-03       Impact factor: 2.401

9.  Clinical and epidemiological relevance of quantitating hepatitis E virus-specific immunoglobulin M.

Authors:  Jitvimol Seriwatana; Mrigendra P Shrestha; Robert M Scott; Sergei A Tsarev; David W Vaughn; Khin Saw Aye Myint; Bruce L Innis
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

10.  The role of hepatitis E virus in acute sporadic non-A, non-B hepatitis.

Authors:  I Köksal; K Aydin; B Kardes; H Turgut; F Murt
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.